CONMED Co. (NYSE:CNMD) Given Average Recommendation of “Moderate Buy” by Analysts

CONMED Co. (NYSE:CNMD – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five ratings firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among […]

Leave a Reply

Your email address will not be published.

Previous post Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Moderate Buy” by Brokerages
Next post Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Moderate Buy” by Brokerages